References: Breast Cancer Virus

Almeida, J. “Virus-like particles in blood of two acute leukemia patients,” Science, vol. 142 (1963): p. 1487.

Andersson, A. “Expression of human endogenous retrovirus ERV3 (HERV-R) mRNA in normal and neoplastic tissues,” International Journal of Oncology, vol. 12 (1998): pp. 309–13.

Andervont, H. and Bryan. W. “Properties of the mouse mammary-tumor agent,” Journal of the National Cancer Institute, vol. 5 (1944): p. 143.

Andervont, H. “Problems Concerning the Tumor Viruses,” in F. M. Burnett and W. M. Stanley, editors, The Viruses (New York: Academy Press, 1959).

Axel, R. “Presence in Human Breast Cancer of RNA homologous to Mouse Mammary Tumour Virus RNA,” Nature, vol. 235 (1972): pp. 32–6.

Baker, Carl. G. An Administrative History of the National Cancer Institute’s Viruses and Cancer Programs, 1950–1972. Available at: http://history.nih.gov/research/downloads/SpecialVirusCaPrgm.pdf

Bang, F. “Electron microscopic evidence concerning the mammary tumor inciter (virus). II. An electron microscopic study of spontaneous and induced mammary tumors of mice,” Bulletin of Johns Hopkins Hospital, vol. 98 (1956): p. 287.

Bang, F. “Electron microscopic evidence concerning the mammary tumor inciter (Virus). I. A study of normal and malignant cells from the mammary gland of mice.” Bulletin of Johns Hopkins Hospital, vol. 98 (1956): p. 255.

Bell, T. “Isolation of a retrovirus from a case of Burkitt’s lymphoma,” British Medical Journal, vol. 1 (1964): p. 1212.

Benit, L. “Identification, Phylogeny, and Evolution of Retroviral Elements Based on Their Envelope Genes,” Journal of Virology, vol. 75, no 23 (2001): pp. 11709–19.

Bera, T. “Defective Retrovirus Insertion Activates c-Ha-ras Proto-oncogene in an MNU-Induced Rat Mammary Carcinoma,” Biochemical and Biophysical Research Communications, vol. 248 (1998): pp. 835–40.

Berkhout, B. “Identification of an Active Reverse Transcriptase Enzyme Encoded by a Human Endogenous HERV-K Retrovirus,” Journal of Virology, vol. 73, no. 3 (1999): pp. 2365–75.

Bindra, A. “Search for DNA of exogenous mouse mammary tumor virus-related virus in human breast cancer samples,” Journal of General Virology, vol. 88 (2007): 1806–1809.

Bittner, J. “Some Possible effects of nursing on the mammary gland tumor incidence in mice,” Science, vol. 84 (August 14, 1936): p. 162.

Bittner, J. “The influence of transplanted normal tissue on breast cancer ratios in mice,” Public Health Report, vol. 54 (1939): p. 1827.

Bittner, J. “The Milk-Influence of Breast Tumors in Mice,” Science, vol. 95 (May 1942): pp. 462–63.

Blair, P. “Neutralization of the mouse mammary tumor virus by rabbit antisera against C3Hf tissue,” Cancer Research, vol. 23 (1963): p. 381.

Bock, M. “Endogenous retroviruses and the human germline,” Current Opinions in Genetics and Development, vol. 10 (2000): pp. 651–55.

Burger D. “Virus-like particles in human leukemic plasma,” Proceedings of the Society for Experimental Biology and Medicine, vol. 115 (1964): p. 151.

Burkitt, D. “A lymphoma syndrome in African children,” Annals of the Royal College of Surgeons, vol. 30 (1962): p. 211.

Burkitt D. “Geographical and tribal distribution of the African Lymphoma in Uganda,” British Medical Journal, vol. 1 (1966): p. 569.

Callahan, R. “Detection and cloning of human DNA sequences related to the mouse mammary tumor virus genome,” Proceedings of the National Academy of Science USA, vol. 79 (1982): pp. 5503–7.

Callahan, R. “MMTV-induced mammary tumorigensis: gene discovery, progression to malignancy and cellular pathways,” Oncogene, vol. 19 (2000): pp. 992–1001.

Dalton A. “Some Ultrastructural Characteristics of a Series of Primary and Transplanted Plasma-Cell Tumors of the Mouse,” Journal of the National Cancer Institute, vol. 26, no. 5 (1961): pp. 1221–66.

Day N. “Antibodies reactive with murine mammary tumor virus in sera of patients with breast cancer: Geographic and family studies,” Proceedings of the National Academy of Science USA, vol. 78 (1984): pp. 2483–87.

DeOme, K. “The mouse mammary tumor virus,” Fed Proc, vol. 12 (1962): p. 15.

Dion, A. “A human protein related to the major envelope protein of murine mammary tumor virus: identification and characterization,” Proceedings of the National Academy of Science USA, vol. 77 (1980): pp. 1301–5.

Dion, A. “Retrovirus association with breast cancer: a critical appraisal,” Breast Cancer Research and Treatment, vol. 9 (1987): pp. 155–56.

Dmochowski, L. “The milk agent in the origin of mammary tumors in mice,” Advances in Cancer Research, vol. 1 (1953): p. 103.

Epstein, M. “Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt’s lymphoma,” Journal of Experimental Medicine, vol. 121 (1965): p. 761.

Ekbom, A. “Breast-feeding and breast cancer in the offspring,” British Journal of Cancer, vol. 67 (1993): pp. 2375–82.

Etkind, P. “Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient,” Clinical Cancer Research, vol. 6 (2000): pp. 1273–78.

Etkind, P. “Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin’s lymphomas of individual patients diagnosed with both malignancies,” Clinical Cancer Research, vol. 10 (2004): pp. 5656–64.

Faedo, M. “Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer,” Clinical Cancer Research, vol. 10 (2004): pp. 4417–19.

Fennelly, J. “Co-amplification of tail-to-tail copies of MuRVY and APE retroviral genomes on the Mus musculus Y Chromosome,” Mammalian Genome, vol. 7 (1996): pp. 31–6.

Fernandez-Cobo, M. “Transcription profiles of non-immortalized breast cancer cells,” Biomed Central Cancer, vol. 6 (2006): pp. 99–100. (BMC Cancer 2006, 6:99)

Ford, C. “Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women,” Clinical Cancer Research, vol. 9 (2003): pp. 1118–20.

Ford, C. “MMTV virus-like RNA transcripts and DNA are found in affected cells of human breast cancer,” Clinical Cancer Research, vol. 10 (2004): pp. 7284–89.

Franklin, G. “Expression of Human Sequences Related to Those of Mouse Mammary Tumor Virus,” Journal of Virology, vol. 62 (1988): pp. 1203–10.

Friedman, G. “Spousal concordance for cancer incidence. A cohort study,” Cancer, vol. 86 (2000): pp. 2413–19.

Fukuoka, H. “No association of mouse mammary tumor virus-related retrovirus with Japanese cases of breast cancer,” Journal of Medical Virology, vol. 80 (2008): pp. 1447–51.

Garb, S. Cure for Cancer: A National Goal (New York: Springer Publishing, 1968).

Gay, F. “Morphogenesis of Bittner Virus,” Journal of Virology, vol. 5 (June 1970): pp. 801–16.

Glenn, W. “Presence of MMTV-like gene sequences may be associated with specific breast cancer morphology,” Journal of Clinical Pathology, vol. 60, no. 9 (2007): p. 1071.

Golovkina T. “Coexpression of Exogenous and Endogenous Mouse Mammary Tumor Virus RNA In Vivo Results in Viral Recombination and Broadens the Virus Host Range,” Journal of Virology, vol. 68 (1994): pp. 5019–26.

Golovkina, T, “Superantigen activity is needed for mouse mammary tumor virus spread within the mammary gland,” Journal of Immunology, vol. 161 (1998): pp. 2375–82.

Golovkina, T. “A novel membrane protein is a mouse mammary tumor virus receptor,” Journal of Virology, vol. 72 (1998): pp. 3066–71.

Gotlieb-Stematsky, T. “Increased tumor formation by polyoma virus in the presence of non-oncogenic viruses,” Nature, vol. 212 (1966): p. 421.

Gray, D. “Activation of int-1 and int-2 Loci in GRf Mammary Tumors,” Virology, vol. 154 (1986): pp. 271–278.

Griffiths, D. “Endogenous retroviruses in the human genome sequence,” Genome Biology, vol. 2, no. 6 (2001): pp. 1017.1–1017.5.

Hachana, M. “Prevalence and characteristics of the MMTV-like associated breast carcinomas in Tunisia,” Cancer Letter, vol. 271 (2008): pp. 222–30.

Hareuveni, M. “Breast cancer sequences identified by mouse mammary tumor (MMTV) antiserum are unrelated to MMTV,” International Journal of Cancer, vol. 46 (1990): pp. 1134–35.

Held, W. “Reverse Transcriptase-dependent and –independent Phases of Infection with Mouse Mammary Tumor Virus: Implications for Superantigen Function,” Journal of Experimental Medicine, vol. 180 (1994): pp. 2347–51.

Heller, J. “Research on cancer viruses,” Public Health Report, vol. 75 (1960): p. 501.

Herbut, P. “Human leukemia virus in mice,” Arch Path, vol. 83 (1967): p. 123. (Archives of Pathology)

Holland, J. Breast Cancer Research Treatment, vol. 11 (2006): Abstract 6.

Holland, J. “The Human Mammary Tumor Virus,” National Institutes of Health Clinical Center Grand Rounds (July 10, 1013). Available at: videocast.nih.gov.

Howard, D. “Isolation of a series of novel variants of murine mammary tumor viruses with broadened host range,” International Journal of Cancer, vol. 25 (1980): pp. 647–54.

Hughes, J. “Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution,” Nature Genetics, vol. 29 (2001): pp. 487–89.

Imai, S. “Distribution of Mouse Mammary Tumor Virus in Asian Wild Mice,” Journal of Virology, vol. 68 (1994): pp. 3437–42.

“Identity crisis,” Nature, vol. 457 (2009): pp. 935–36. Editorial.

Indik, S. “Mouse mammary tumor virus infects human cells,” Cancer Research, vol. 65 (2005): pp. 6651–59.

Indik, S. “A novel, mouse mammary tumor virus encoded protein with Rev-like properties,” Virology, vol. 337 (2005): pp. 1–6.

Inkik, S. “Rapid spread of mouse mammary tumor virus in cultured human breast cells,” Retrovirology, vol. 4 (2007): p. 73.

Karlsson, H. “Retroviral RNA identified in the cerebrospinal fluids of brains of individuals with schizophrenia,” PNAS, vol. 98, no 6 (2001): pp. 4634–39. (Proc Natl Acad Sci)

Katz, E. “MMTV env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture,” Journal of Experimental Medicine, vol. 201 (2005): pp. 431–439.

Kerin, M. “Synchronous metastatic breast cancer in husband and wife,” Irish Journal of Medical Science, vol. 165 (1996): p. 50.

Kidd, J. “The enduring partnership of a neoplastic virus and carcinoma cells. Continued increase of virus in the V2 carcinoma during propagation in virus immune hosts,” Journal of Experimental Medicine, vol. 75 (1942): p. 7.

Kuhn, T. The Structure of Scientific Revolutions, third edition. (Chicago, IL.: The University of Chicago Press, 1996).
Larson, E. “Human Endogenous Proviruses,” Current Topics in Microbiology and Immunology, vol. 148 (1989): pp. 115–132.

Lawson J. “From Bittner to Barr: a viral, diet and hormone breast cancer aetiology hypothesis,” Breast Cancer Research, vol. 3 (2001): 81–5.

Leib, C. “Endogenous Retroviral Elements in Human DNA,” Cancer Research (Supplement), vol. 50 (1990): pp. 5636–42.

Levine, P. “Increased incidence of mouse mammary tumor virus-related antigen in Tunisian patients with breast cancer,” International Journal of Cancer, vol. 3 (1984): pp. 305–8.

Levine, P. “Increasing evidence for a human breast carcinoma virus with geographic differences,” Cancer, vol. 101 (2004): pp. 721–26.

Levine, P. “Increased detection of breast cancer virus sequences in inflammatory breast cancer,” Advances in Tumor Virology. vol. 1 (2009): pp. 3–7.

Links, J. “The Growth Accelerating Effect of Bittner Virus in Monolayers of Baby Mouse Kidney Cells,” Journal of General Virology, vol. 5 (1969): pp. 547–50.

Litvinov, S. “Expression of proteins immunologically related to murine mammary tumor virus (MMTV) core proteins in cells of breast cancer continuous cell lines MCF7, T47D, MDA-MB231 “and cells from human milk,” Acta Virologica, vol. 33 (1989): pp. 137–42.

Liu, B. “Identification of a proviral structure in human breast cancer,” Cancer Research, vol. 61 (2001): pp. 1754–59.

Lloyd, R. “Murine mammary tumor virus related antigen in human male mammary carcinoma,” Cancer, vol. 51 (1983): pp. 654–61.

Lower, R. “A general method for the identification of transcribed retrovirus sequences (R-U5 PCR) reveals the expression of the human endogenous retrovirus loci HERV-H and HERV-K in teratocarcinoma cells,” Virology, vol. 192 (1992): pp. 501–11.

Lower, R. “The pathogenic potential of endogenous retroviruses: facts and fantasies,” Trends in Microbiology, vol. 7, no. 9 (1999): pp. 350–56.

Luo, T. “Study of mouse mammary tumor virus-like gene sequences expressing breast tumors of Chinese women,” Sichuan Da Xue Xue Bao Yi Xue Ban, vol. 37 (2006): pp. 844–46.

Lushnikova, A. “Detection of the env MMTV-homologous sequences in mammary carcinoma patient intestine lymphoid tissue,” Doklady Biological Sciences, vol. 399 (2004): pp. 423–26.

Lynch, H. “Is cancer communicable?” Medical Hypotheses, vol. 14 (1984): pp. 181–98.

MacMahon, B. “Etiology of human breast cancer: a review,” Journal of the National Cancer Institute, vol. 50 (1973): pp. 21–42.

Mager, D. “HERV-H endogenous retroviruses: presence in the new world branch but amplification in the old world primate lineage,” Virology, vol. 213 (1995): pp. 395–404.

Mager, D. “Novel Mouse Type D Endogenous Proviruses and Elements Share Long Terminal Repeat and Internal Sequences,” Journal of Virology, vol. 74, no. 16 (2000): pp. 7221–29.

Mant, C. “A human murine mammary tumor virus-like agents are genetically distinct from endogenous retroviruses and not detectable in breast cancer cell lines of biopsies,” Virology, vol. 318 (2004): pp. 393–403.

Marchetti, A. “Host Genetic Background Effect o the Frequency of Mouse Mammary Tumor Virus-Induced Rearrangements of the int-1 and int-2 Loci in Mouse Mammary Tumors,” Journal of Virology, vol. 65, no. 8 (1991): pp. 4550–54.

Marrack, P. “A maternally inherited superantigen encoded by a mammary tumour virus,” Nature, vol. 349 (1991): pp. 524–25.

Melana, S. “Search for mouse mammary tumor virus-like env sequences in cancer and normal breast from the same individuals,” Clinical Cancer Research, vol. 7 (2001): pp. 283–84.

Melana, S. “Characterization of viral particles isolated from primary cultures of human breast cancer cells,” Cancer Research, vol. 67 (2007): pp. 8960–65.

Mesa-Tejada, R. “Detection in human breast carcinomas of an antigen immunologically related to a group-specific antigen of mouse mammary tumor virus,” Proceedings of the National Academy of Science USA, vol. 75 (1978): pp. 1529–33.

Mettenleiter,W. “Isolation of viral agents from human blood and their relationship to lymphatic leukemia,” Oncologia, vol. 16 (1963): p. 307.

Moore, D. “Search for a human breast cancer virus,” Nature, vol. 229 (1971): pp. 611–15.

Morton, D. “Acquired immunological tolerance to spontaneous mammary adenocarcinomas following neonatal infection with mammary tumor agent,” Proceedings of the American Association of Cancer Research, vol. 5 (1964): p. 46.

Mueller-Lantzsch, N. “Human Endogenous Retroviral Element K10 (KERV-K10) Encodes a Full-Length Gag Homologous 73-kDa Protein and a Functional Protease,” AIDS Research and Human Retroviruses, vol. 9, no. 4 (1993): 343–50.

Nusse, R. “The int genes in mammary tumorigenesis and in normal development,” TIG, vol. 4, no. 10 (1988): pp. 291–95. (Trends in Genetics)

Nusse, R. “Insertional Mutagenesis in Mouse Mammary Tumorigenesis,” Current Topics in Microbiology and Immunology, vol. 171 (1991): pp. 43–65.

Ono, M. “Stimulation of Expression of the Human Endogenous Retrovirus Genome by Female Steroid Hormones in Human Breast Cancer Cell Line T47D,” Journal of Virology, vol. 61 (1987): pp. 2059–62.

Paces, J. “HERV: database of human endogenous retroviruses,” Nucleic Acids Research, vol. 30, no 1 (2002): pp. 205–6.

Palmarini, M. “The Exogenous Form of Jaagsiekte Retrovirus Is Specifically Associated with a Contagious Lung Cancer of Sheep,” Journal of Virology, vol. 70, no. 3 (1996): pp. 1618–23.

Peters, G. “Tumorigenesis by Mouse Mammary Tumor Virus: Evidence for a Common Region for Provirus Integration in Mammary Tumors,” Cell, vol. 33, no. 2 (1983): 369–77.

Pitelka, D. “Virus-like particles in precancerous hyperplastic mammary tissues of C3H and C3hf mice,” Journal of the National Cancer Institute, vol. 25 (1960): p. 753.

Pogo, B. “Detection of mammary tumor virus env gene-like sequences in human breast cancer,” Cancer Research, vol. 55 (1995): pp. 5173–79.

Pogo, B. “Possibilities of a Viral Etiology for Human Breast Cancer, A Review,” Biological Trace Element Research, vol. 56 (1997): pp. 131–42.

Pogo, B. “Sequences homologous to the MMTV env gene in human breast carcinoma correlate with overexpression of laminin receptor,” Clinical Cancer Research, vol. 5 (1999): pp. 2108–11.

Prak, E. “Mobile Elements and the Human Genome,” Nature Reviews Genetics, vol. 1 (2000): pp. 134–44.

Prince, A. “Virus like-particles in human plasma and serum from leukemic, hepatitic and control patients,” Fed Proc, vol. 24 (1965): p. 175. (Federation Proc – I found it referenced in “Survey of Viral Oncology …” by Carl Baker et al, Cancer Research, June 1966)

Rettig, Richard A. Cancer Crusade: The Story of the National Cancer Act of 1971. Authors Choice Press, New York. 2005 (Princeton University Press, 1977)

Reus, K. “HERV-K (OLD): Ancestor Sequences of the Human Endogenous Retrovirus Family HERV-K (HNL-2),” Journal of Virology, vol. 75, no. 19 (2001): pp. 8917–26.

Reuss, F. “cDNA Sequence and Genomic Characterization of Intracisternal A-Particle-Related Retroviral Elements Containing an Envelope Gene,” Journal of Virology, vol. 65, no. 11 (1991): pp. 5702–9.

Rous, P. “A sarcoma of the fowl transmissible by an agent separable from the tumor cells,” Journal of Experimental Medicine, vol. 13 (1911): p. 397.

Rous, P. “Transmission of a malignant new growth by means of a cel-free filtrate,” Journal of the American Medical Association, vol. 56 (1911): p. 198.

Russ, J. “Identical cancers in husband and wife,” Surgery, Gynecology, and Obstetrics, vol. 150 (1980): pp. 664–66.

Salmons, B. “Production of mouse mammary tumor virus upon transfection of a recombinant proviral DNA into cultured cells,” Virology, vol. 144 (1985): pp. 101–14.

Sarkar, N. “Type B virus and human breast cancer” in The Role of Viruses in Human Cancer, volume 1. A. Giraldo and A. Beth, editors (North Holland: Elsevier, 1980): pp. 207–35.

Shackleford, G. “Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-1/Fgf-3 and hst/Fgf-4,” Proceedings of the National Academy of Science USA, vol. 90 (1993): pp. 740–44.

Smit, A. “Interspersed repeats and other mementos of transposable elements in mammalian genomes,” Current Opinion in Genetics & Development, vol. 9 (1999): pp. 657–63.

Steintz, R. “Male breast cancer in Israel: selected Epidemiological aspects,” Israel Journal of Medical Science, vol. 17 (1981): pp. 816–21.

Stewart, A. “Identification of Human Homologues of the Mouse Mammary Tumor Virus Receptor,” Archives of Virology, vol. 147 (2002): pp. 577–81.

Stewart, S. “Burkitt’s tumour: tissue culture, cytogenetic and virus studies,” Journal of the National Cancer Institute, vol. 34 (1964): p. 319.

Stewart, T. “Breast Cancer Incidence Highest in the Range of One Species of House Mouse, Mus Domesticus,” British Journal of Cancer, vol. 82 (2000): pp. 446–51.

“Sumidaie, A. “Particles with Properties of Retroviruses in Monocytes from Patients with Breast Cancer,” Lancet, vol. 1, nos. 8575-6 (1988): pp. 5–9.

Szabo, S. “Of Mice, Cats and Men: Is human breast cancer a zoonosis?” Microscopy Research and Technique, vol. 68 (2005): pp. 197–208.

Tchenio, T. “Defective Retroviruses Can Disperse in the Human Genome by Intracellular Transposition,” Journal of Virology, vol. 65 (1991): pp. 2113–18.

“Jobless Little,” Time, vol. 7, no. 5 (February 4, 1929). (No author listed.)

Unknown Author, “Cancer Army,” Time, vol. 29, no. 12. (March 22, 1937): p. 56.

“Cancer Virus,” Time (March 18, 1946).

Tonjes, R. “Characterization of Human Endogenous Retrovirus Type K Virus-like Particles Generated from Recombinant Baculoviruses,” Virology, vol. 233 (1997): pp. 280–291.

Tristem, M. “Identification and Characterization of Novel Human Endogenous Retrovirus Families by Pylogenetic Screening of the Human Genome Mapping Project Database,” Journal of Virology, vol. 74, no. 8 (2000): pp. 3715–30.

Tsubura, A. “Intervention of T-cells in transportation of mouse mammary tumor virus to mammary gland cells in vivo,” Cancer Research, vol. 48 (1988): pp. 6555–59.

Turner, G. “Insertional polymorphisms of full-length endogenous retroviruses in human,” Current Biology, vol. 11 (2001): pp. 1531–35.

Wang, Y. “Detection of mammary tumor virus env gene-like sequences in human breast cancer,” Cancer Research, vol. 55 “(1995): pp. 5173–79.

Wang, Y. “Expression of mouse mammary tumor virus-like env gene sequences in human breast cancer,” Clinical Cancer Research, vol. 4 (1998): pp. 2565–68.

Wang, Y. “Detection of MMTVlike LTR and LTR-env gene sequences in human breast cancer,” International Journal of Oncology, vol. 18 (2001): pp. 1041–44.

Wang, Y. “Presence of MMTV-like env gene sequences in gestational breast cancer,” Medical Oncology, vol. 20 (2003): pp. 233–36.

Wang, Y. “A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer,” Cancer Research, vol. 64 (2004): pp. 4105–11.

Westley, B. “The human genome contains multiple sequences of varying homology to mouse mammary tumour virus DNA,” Gene, vol. 28 (1984): pp. 221–27.

Wetchler, B. “Carcinoma of the breast occurring in a husband and wife: a brief communication,” Mt. Sinai Journal of Medicine, vol. 42 (1975): pp. 205–6.

Witkin, A. “Antigens and antibodies cross-reactive to the murine mammary tumor virus in human breast cyst fluids,” Journal of Clinical Investigation, vol. 67 (1981): pp. 216–22.

Witt, A. “The mouse mammary tumor virus-like sequence is not detectable in breast cancer tissue of Austrian patients,” Oncology Report, vol. 10 (2003): pp. 1025–29.

Wright, D. “Burkitt’s tumor and childhood lymphosarcoma,” Clinical Pediatrics, vol. 6 (1967): p. 116.

Xu, L. “Does a betaretrovirus infection trigger primary biliary cirrhosis?” Proceedings of the National Academy of Science, vol. 100 (2003): pp. 8454–59.

Yang, M. “Presence of a mouse mammary tumor virus MMTV-related antigen in human breast carcinoma cells and its absence from normal epithelial cells,” Journal of the National Cancer Institute, vol. 61 (1978): pp. 1205–7.

Zammarchi, F. “MMTV-like sequences in human breast cancer: a fluorescent PCR/laser microdissection approach,” Journal of Pathology, vol. 209 (2006): pp. 436–44.

Zangen, R. “Mouse mammary tumor-like envgene as a molecular marker for breast cancer?” International Journal of Cancer, vol. 102 (2002): pp. 304–7.

Zapata-Benavides, P. “Mouse mammary tumor virus-like gene sequences in breast cancer samples of Mexican women,” Intervirology, vol. 50 (2007): pp. 402–7.

Zotter, S. “Mouse Mammary Tumour Virus-related Antigens in Core-like Density Fractions from Large Samples of Women’s Milk,” European Journal of Cancer, vol. 16 (1980): pp. 455–67.

36 Newark Ave., Suite 130
Belleville, NJ  07109

(973) 450-2710